Glipizide extended release tablets
1 INDICATIONS AND USAGE Glipizide extended-release tablets is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glipizide extended-release tablets are a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use: Not for treatment of type 1 diabetes or diabetic ketoacidosis. 1.1 Limitations of Use Glipizide extended-release tablets are not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
par pharmaceutical, inc.
ROUND WHITE Logo 325
Related Pills
Myrbetriq 24 HR mirabegron 25 MG Extended Release Oral Tablet Myrbetriq
Astellas Pharma US, Inc.
belsomra suvorexant tablet film coated
merck sharp & dohme corp.
Myrbetriq 24 HR mirabegron 25 MG Extended Release Oral Tablet Myrbetriq
Astellas Pharma US, Inc.
belsomra tablet film coated
merck sharp & dohme corp.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Glipizide Extended Release Tablets are supplied as follows: 5 mg – Each pink, film-coated, round tablet with an indentation hole on one side, with and ‘324’ printed in black ink on either side, contains 5 mg of glipizide, USP. Tablets are supplied in bottles of 100 (NDC 49884-745-01) with child-resistant closure and 500 (NDC 49884-745-05) without a child-resistant closure. 10 mg – Each white, film-coated, round tablet with an indentation hole on one side, with and ‘325’ printed in black ink on either side, contains 10 mg of glipizide, USP. Tablets are supplied in bottles of 100 (NDC 49884-746-01) with child-resistant closure and 500 (NDC 49884-746-05) without a child-resistant closure. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. PROTECT FROM MOISTURE AND HUMIDITY. Dispense in a tight, light-resistant container as defined in the USP. Do not crush. Tablet-imprint Tablet-imprint
More pills like ROUND Logo 325